The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
Treatment
2017 annual bulletin, National Observatory on drugs of Guatemala
INTRODUCTION The National Observatory on drugs (OND) of the SECCATID works in the Constitution of a network of information on drugs (RID) in Guatemala, with the members of the Commission against addiction and illicit drugs - CCATID - and...
Neither Myth nor Stigma: Mainstreaming Mental Health in Developing Countries
Abstract Mental and substance use disorders account for 18.9% of years lived with disability worldwide. A rising prevalence of mental disorders was identified in the past decade and a call for global attention to this challenge was made...
Evaluating Clinical Stop‐Smoking Services Globally: Towards a Minimum Data Set
Abstract Background and aims Behavioural and pharmacological support for smoking cessation improves the chances of success and represents a highly cost‐effective way of preventing chronic disease and premature death. There is a large number...
Single‐Dose Bioequivalence of Two Mini Nicotine Lozenge Formulations
Abstract Diverse nicotine replacement therapy options may improve consumer usage. This study was conducted to establish the bioequivalence of a new cherry‐flavored mini lozenge with that of a currently marketed mint‐flavored mini lozenge...
Cost‐Effectiveness of Increasing the Reach of Smoking Cessation Interventions in Germany
Abstract Aims To evaluate costs, effects and cost‐effectiveness of increased reach of specific smoking cessation interventions in Germany. Design A Markov‐based state transition return on investment model (EQUIPTMOD) was used to evaluate...
Mesenchymal Stem Cell Therapy for Advanced Liver Cirrhosis: A Case Report
Abstract Mesenchymal stem cell (MSC) transplant may offer an alternative to liver transplantation in patients with end‐stage liver disease. However, its efficacy remains uncertain. MSC was performed on a 50‐year‐old male with decompensated...
Mindfulness-Based Treatment of Addiction: Current State of the Field and Envisioning the Next Wave of Research
Abstract Contemporary advances in addiction neuroscience have paralleled increasing interest in the ancient mental training practice of mindfulness meditation as a potential therapy for addiction. In the past decade, mindfulness-based...
Guidelines on the Management of Co-Occurring Alcohol and Other Drug and Mental Health Conditions in Alcohol and Other Drug Treatment Settings
First published in 2009 and updated in 2014 the Guidelines on the Management of Co-Occurring Alcohol and Other Drug and Mental Health Conditions in Alcohol and Other Drug Treatment Settings are offered in tandem with an online training...
Glossary of Terms Used in Drug Policy
A glossary of drug policy terminology produced by the Drug Policy Network South East Europe is now available in English and Spanish. The Drug Policy Network South East Europe (DPNSEE) is an initiative of NGOs from the countries of South...
The European Health Award 2018
Applications are now open for the European Health Awards. Coordinated by the European Health Forum Gastein (EHFG), the awards are offered to public health and healthcare initiatives in Europe. The award focuses on projects disparities in...